Target intelligence / Profile preview

Dachshund family transcription factor 1 (DACH1)

Target
DACH1
Molecular classification
Transcription factor, Chromatin-associated protein, Ski protein family
01

Overview

Dachshund family transcription factor 1 (DACH1) is a chromatin-associated transcription factor encoded by the DACH1 gene on chromosome 13q22. It contains conserved domains similar to Drosophila dachshund and Ski protein family members, with broad expression in multiple tissues. DACH1 plays key roles in development (especially of the eye, kidney, and neural tissues), cell fate determination, and gene regulation. In adults, DACH1 functions predominantly as a tumor suppressor by repressing cell proliferation, migration, and EMT, and by modulating hormone receptor signaling (including estrogen and androgen receptor pathways). Loss of DACH1 expression is linked to tumor progression in several solid cancers and is associated with poor prognosis. It is also implicated in renal development/disease, chromosomal rearrangements in leukemia, and metabolic regulation in the liver[1][2][3].

Other names
Dachshund homolog 1DACH1DACHDach1Dachshunddac homolog
02

Mechanism of action

Not directly drug-targeted; mechanisms involve modulation of gene transcription, co-repressor recruitment, inhibition of oncogenic and hormone receptor signaling, repression of cell cycle proteins (e.g., Cyclin D1)[1][2]

03

Biological functions

Regulation of gene expressionCell fate determination during developmentTumor suppressionInhibition of cell proliferationInhibition of cell migrationRegulation of mRNA translationModulation of hormone receptor activityRegulation of epithelial-mesenchymal transition (EMT)
04

Disease associations

Cancer (breast, lung, prostate, brain, colorectal, pancreatic, renal)Nephropathy/renal diseaseDiabetes (hepatic insulin resistance)Acute lymphoblastic leukemia (chromosomal rearrangement involvement)
05

Safety considerations

Potential safety concern is that DACH1 is essential for normal developmental processes; off-target modulation may impair organogenesis or cell fate[1][2]
06

Biomarkers

Loss or reduction in DACH1 expression is considered a poor prognostic biomarker in several cancers (breast, lung, prostate, colorectal)[2]

Beyond the preview

Go deeper on Dachshund family transcription factor 1 (DACH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dachshund family transcription factor 1 (DACH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call